ARTINESS Announces Closing of an Equity Round of Investment to Boost further Development of its Technology ARTICOR

July 15, 2024 06:30 PM AEST | By EIN Presswire

Google News:

ARTINESS Announces Closing of an Equity Round of Investment to Boost further Development of its Technology ARTICOR — Image source: EIN Presswire

Recent News

CSL Ltd (ASX:CSL) Strengthens Healthcare Footprint in ASX Top 300

ASX 200 Gains Ground as Tech and Energy Stocks Show Upward Momentum

Shanghai summer kicks off with 'Easy Go'

Goodman Group and Sonic Healthcare Maintain Market Strength in ASX Lan...

ARTINESS successfully closed an equity round led by Sorean, with nVue Surgical as Industrial Partner, and a group of Business Angels. MILANO, MI, ITALY, July 15, 2024 /EINPresswire.com/ -- The round was led by Sorean, with nVue Surgical as Industrial Partner, followed by a group of Business Angels.

The company is planning to use the proceeds from this round to move further on with the clinical and market validation activities in Europe and extend the support to the first centers in the USA that are using ARTICOR technology, pursuing FDA clearance, and increasing the internal team resources.

ARTINESS srl, an Italy-based medical device company, has conceived a new technology for interventional and surgical support, bringing pre-operative planning to a higher level through a software platform based on advanced 3D patient-specific modeling and procedural planning tools combined with high-end mixed reality visualization to ensure high usability, fast decision-making, and intuitive discussions within the interventional and surgical team.

ARTINESS is committed to transforming interventional and surgical procedures, with a specific focus on structural heart transcatheter approaches.

“This round marks an important moment in our journey to revolutionize interventional and surgical procedures with our groundbreaking ARTICOR technology. Our new shareholders are bringing a great mix of expertise in strategy and business development. This infusion of knowledge and capital is pivotal as we consolidate our technology and move forward with market validation in Europe and the USA”, stated Filippo Piatti, CEO and co-founder of ARTINESS.

“ARTINESS represents a highly disruptive reality in the market of high technology medical devices and we are convinced that Sorean can provide a significant contribution to accelerate the growth and the empowerment process, aiming to make the Company one of the leading market players”, stated Gianni Anania, CEO of SOREAN.

The round was supported by
Angelo Romano partner of LMCR Studio Legale (https://www.lmclex.it/lmcr/it/home/) and Cristiano Fontana
Musumeci, Altara, Desana e Associati Studio Legale (http://madlex.it/), and Madison Corporate Finance (https://madisonfinance.it/)
for the due diligence and closing phases.

Stay tuned for further developments from ARTINESS and find out more at

webiste: https://www.artinessreality.com/
linkedin: https://www.linkedin.com/company/artinessreality

---
ARTINESS srl
[email protected]

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.